BlueCrest Capital Management’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-18,047
Closed -$257K – 1508
2018
Q3
$257K Buy
18,047
+7,895
+78% +$107K 0.01% 1124
2018
Q2
$122K Buy
+10,152
New +$125K ﹤0.01% 1377
2017
Q3
– Sell
-20,652
Closed -$264K – 1134
2017
Q2
$264K Buy
20,652
+4,265
+26% +$51.8K 0.01% 714
2017
Q1
$208K Sell
16,387
-61,639
-79% -$731K 0.01% 613
2016
Q4
$797K Buy
78,026
+34,361
+79% +$392K 0.04% 405
2016
Q3
$575K Buy
+43,665
New +$584K 0.02% 484
2016
Q1
– Sell
-324,548
Closed -$4.99M – 1177
2015
Q4
$4.99M Buy
+324,548
New +$4.65M 0.21% 104
2015
Q3
– Sell
-26,748
Closed -$366K – 1083
2015
Q2
$366K Sell
26,748
-37,792
-59% -$510K 0.01% 681
2015
Q1
$772K Buy
+64,540
New +$789K 0.04% 396

Other funds holding MDRX

BlueCrest Capital Management's MDRX Position: Q4 2018 in Review

BlueCrest Capital Management sold out of Veradigm Inc. Common Stock (MDRX) in Q4 2018, closing a stake of 18,047 shares — an estimated $257K sold.

BlueCrest Capital Management first reported a position in MDRX in Q1 2015 and held it in 9 quarters. The position peaked at $4.99M in Q4 2015. 222 funds tracked by Wall St. Rank hold MDRX as of Q4 2018.

  • BlueCrest Capital Management reported no remaining Veradigm Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 18,047 Veradigm Inc. Common Stock shares in Q4 2018, an estimated $257K.
  • BlueCrest Capital Management first reported a position in Veradigm Inc. Common Stock in Q1 2015 and held it in 9 quarters.
  • BlueCrest Capital Management's Veradigm Inc. Common Stock position peaked at $4.99M in Q4 2015.
  • 222 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.